Article
Current landscape of vector safety and genotoxicity after hematopoietic stem or immune cell gene therapy
8 Apr 2025
Abstract excerpt
Malignant transformation of gene modified haematopoietic stem cells caused anxiety following adverse events in early clinical trials using gamma-retroviral vectors (γRV) to correct haematopoietic stem cells (HSC) in monogenic immune disorders. Adoption of HIV-derived lentiviral vectors (LV) with SIN (self-inactivating) configurations greatly reduced risks and subsequently hundreds of patients have been dosed with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
